Takeda Pharmaceutical Company Limited
4502
Ранг среди акций
#377
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Цена акции
$40.31
Рыночная капитализация
$64.13B
Изменение (1 день)
0.82%
Изменение (1 год)
42.59%
Страна
JP
Торговля Takeda Pharmaceutical Company Limited (4502)
Категория
Healthcare
История дроблений акций Takeda Pharmaceutical Company Limited (4502)
Акции Takeda Pharmaceutical Company Limited (символ: 4502) прошли через 0 дроблений.
Последнее дробление произошло Oct 22, 2026.
Одна акция 4502, купленная до Oct 22, 2026, сейчас соответствует 0 акциям 4502.
Последнее дробление произошло Oct 22, 2026.
Одна акция 4502, купленная до Oct 22, 2026, сейчас соответствует 0 акциям 4502.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
|
| 0 | - |
CN
|
